Sr One Capital Management, LP Crispr Therapeutics Ag Transaction History
Sr One Capital Management, LP
- $295 Million
- Q3 2024
A detailed history of Sr One Capital Management, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sr One Capital Management, LP holds 1,048,951 shares of CRSP stock, worth $41.6 Million. This represents 16.68% of its overall portfolio holdings.
Number of Shares
1,048,951
Previous 1,048,951
-0.0%
Holding current value
$41.6 Million
Previous $56.7 Million
13.0%
% of portfolio
16.68%
Previous 24.88%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
489Shares Held
57.9MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$315 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$298 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$119 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$118 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$118 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.1B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....